WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (“CRS”), today announced the appointment of Ronan O’Brien, as Chief Legal Officer, effective October 16, 2023.
BlogofInnovation.com
NASHVILLE, Tenn., Dec. 11, 2024 — Representatives from 20 local Metro Nashville Public Schools (MNPS) joined the American Heart Association…
MESA, Ariz., Dec. 11, 2024 (SEND2PRESS NEWSWIRE) — Edupoint® Educational Systems, creator of the industry-leading Synergy® Education Platform for K-12…
FREMONT, Calif. - (NewMediaWire) - December 11, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions…
NEW YORK, N.Y., Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — HitPaw, a leading software company, is excited to announce the new…
DALLAS, Texas, Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — ProNotary, a pioneering force in the remote online notarization (RON) industry, today…
DALLAS, Dec. 10, 2024 — Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure,…
